Celldex Therapeutics reported $-23050000 in Pre-Tax Profit for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Pre Tax Profit Change
Abbvie ABBV:US $ 6567M 197M
Agenus AGEN:US $ -50.6M 17M
Amgen AMGN:US $ 2727M 56M
Applied Genetic Technologies AGTC:US $ -14.24M 4.87M
Biocept BIOC:US $ -2.77M 0.08M
Bristol Myers Squibb BMY:US $ 5386M 595M
Celldex Therapeutics CLDX:US $ -23.05M 2.9M
Immunogen IMGN:US $ -24.14M 13.03M
Nektar Therapeutics NKTR:US $ -90.27M 55.38M
Newlink Genetics NLNK:US $ -7.72M 1.44M
Pfizer PFE:US $ 11328M 4083M
Rigel Pharmaceuticals RIGL:US $ -27.44M 4.74M
Seattle Genetics SGEN:US $ -135.24M 41.73M